Rhinosinusitis

IDSA Rhinosinusitis Guidelines

IDSA Rhinosinusitis GUIDELINES App brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/88047

Contents of this Issue

Navigation

Page 10 of 11

Figure 3. Algorithm for the Management of ABRS Signs and symptoms (any one): > Persistent and not improving (≥ 10 days) > Severe (≥ 3-4 days) or > Worsening or "double-sickening" (≥ 3-4 days) Risk for antibiotic resistance? NO Initiate 1st antimicrobial therapy line Symptomatic management YES Initiate 2nd antimicrobial therapy line Improvement after 3-5 days antimicrobial therapy* Complete 5-7 days of Improvement antimicrobial therapy Complete 5-7 days of Risk for antibiotic resistance > Age < 2 or > 65, day care > Prior antibiotics within the past month > Prior hospitalization past 5 days > Comorbidities > Immunocompromised * In children, complete 10-14 days of antimicrobial therapy. improvement after 3-5 days Worsening or no Broaden coverage or switch to different antimicrobial class improvement after 3-5 days Refer to specialist Worsening or no > CT or MRI to investigate noninfectious causes or suppurative complications Improvement after 3-5 days antimicrobial therapy* Complete 7-10 days of Improvement antimicrobial therapy Complete 7-10 days of > Sinus or meatal cultures for pathogen-specific therapy

Articles in this issue

Archives of this issue

view archives of Rhinosinusitis - IDSA Rhinosinusitis Guidelines